Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wenjun Liao

Showing results (141-150 of 144) with videos related to

Pageof 15
Sort By:
You have reached the last page of results.This site can display upto 144 results.
European Thyroid Journal|October 29, 2025
Extreme resistance to thyroid hormone caused by a novel mosaic thyroid hormone receptor beta mutationFerdy S van Geest, Wenjun Liao, Paul G Voorhoeve, et al.
Medical Image Analysis|May 11, 2026
SegRap2025: A benchmark of gross tumor volume and lymph node clinical target volume Segmentation for Radiotherapy Planning of nasopharyngeal carcinomaJia Fu, Litingyu Wang, He Li, et al.
Cancer Letters|August 22, 2025
A multicenter, real-world study analysis: pembrolizumab changes treatment strategy for the patient with recurrent/metastatic head and neck squamous cell carcinomaMan Hu, Xia Li, Hong Feng, et al.
Medical Image Analysis|January 5, 2025
SegRap2023: A benchmark of organs-at-risk and gross tumor volume Segmentation for Radiotherapy Planning of Nasopharyngeal CarcinomaXiangde Luo, Jia Fu, Yunxin Zhong, et al.
Pageof 15

Showing results (141-150 of 144) with videos related to

Sort By:
Pageof 15
You have reached the last page of results.This site can display upto 144 results.
European Thyroid Journal|October 29, 2025
Extreme resistance to thyroid hormone caused by a novel mosaic thyroid hormone receptor beta mutationFerdy S van Geest, Wenjun Liao, Paul G Voorhoeve, et al.
Medical Image Analysis|May 11, 2026
SegRap2025: A benchmark of gross tumor volume and lymph node clinical target volume Segmentation for Radiotherapy Planning of nasopharyngeal carcinomaJia Fu, Litingyu Wang, He Li, et al.
Cancer Letters|August 22, 2025
A multicenter, real-world study analysis: pembrolizumab changes treatment strategy for the patient with recurrent/metastatic head and neck squamous cell carcinomaMan Hu, Xia Li, Hong Feng, et al.
Medical Image Analysis|January 5, 2025
SegRap2023: A benchmark of organs-at-risk and gross tumor volume Segmentation for Radiotherapy Planning of Nasopharyngeal CarcinomaXiangde Luo, Jia Fu, Yunxin Zhong, et al.
Pageof 15